Evidence map›Paper›PMID 34348284›Full record

ArticleCardiology

A Novel SCN5A Variant Causes Temperature-Sensitive Loss Of Function in a Family with Symptomatic Brugada Syndrome, Cardiac Conduction Disease, and Sick Sinus Syndrome.

Karolina Sanner, Johanna Mueller-Leisse, Christos Zormpas, David Duncker, Andreas Leffler, Christian Veltmann

Open access · hybridAbstract read
In one paragraph

Article in Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. SCN5AInternational journal of legal medicine · 2026
    Article
  2. Biophysical mechanisms of myocardium sodium channelopathies.Pflugers Archiv : European journal of physiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Karolina SannerDepartment of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Johanna Mueller-LeisseRhythmology and Electrophysiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Christos ZormpasRhythmology and Electrophysiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
David DunckerRhythmology and Electrophysiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Andreas LefflerDepartment of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany, leffler.andreas@mh-hannover.de.
Christian VeltmannRhythmology and Electrophysiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBrugada syndrome (BrS) is an inherited arrhythmia syndrome associated with an increased risk of sudden cardiac death. SCN5A is the most important disease-modifying gene for BrS, but many SCN5A variants have not been functionally characterized. Furthermore, the temperature dependency of SCN5A is only rarely explored in in vitro analyses.

methodsThe clinical phenotype of the affected family was assessed by medical history, ECGs and ajmaline challenge. Whole-cell patch clamp recordings were performed on HEK 293T cells expressing Nav1.5-G1712S, a novel SCN5A variant found in the symptomatic family.

resultsThree male family members had experienced sudden cardiac death, sudden cardiac arrest, and rhythmogenic syncopes. Beside a positive ajmaline challenge with demarcation of a Brugada type 1 ECG, 1 patient also showed evidence of symptomatic cardiac conduction disease and sick sinus syndrome (SSS). In patch clamp analyses, Nav1.5-G1712S generated reduced peak currents as compared to the wild type. At body temperature, Nav1.5-G1712S additionally exhibited an enhanced slow inactivation and an impaired recovery from inactivation.

conclusionWe conclude that G1712S is a pathogenic SCN5A loss-of function mutation at physiological temperature associated with an overlapping presentation of BrS, SSS, and cardiac conduction disease.

Indexed as

Brugada SyndromeNAV1.5 Voltage-Gated Sodium ChannelSick Sinus SyndromeHumansMaleTemperatureNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanBrugada syndromeCardiac conduction diseaseChannelopathyNav1.5

Identifiers

PMID34348284
PMCPMC8743901
OpenAlexW3180623065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.